Uncorrected Proof scheduled for 27 (4)

Urinary Calprotectin as a Marker to Distinguish Functional and Structural Acute Kidney Injury in Pediatric Population

Authors Information
Article Notes and Dates
To Cite : Basiratnia M, Kosimov M, Farhadi P, Azimi A, Hooman N. et al. Urinary Calprotectin as a Marker to Distinguish Functional and Structural Acute Kidney Injury in Pediatric Population, Iran J Pediatr. Online ahead of Print ;In Press(In Press):e9727. doi: 10.5812/ijp.9727.
Abstract
1. Background
2. Methods
3. Results
4. Discussion
References
  • 1. Koyner JL, Cerda J, Goldstein SL, Jaber BL, Liu KD, Shea JA, et al. The daily burden of acute kidney injury: a survey of U.S. nephrologists on World Kidney Day. Am J Kidney Dis. 2014; 64(3): 394-401[DOI][PubMed]
  • 2. Lewington AJ, Cerda J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int. 2013; 84(3): 457-67[DOI][PubMed]
  • 3. Moffett BS, Goldstein SL. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol. 2011; 6(4): 856-63[DOI][PubMed]
  • 4. Menon S, Kirkendall ES, Nguyen H, Goldstein SL. Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months. J Pediatr. 2014; 165(3): 522-7 e2[DOI][PubMed]
  • 5. Alkandari O, Eddington KA, Hyder A, Gauvin F, Ducruet T, Gottesman R, et al. Acute kidney injury is an independent risk factor for pediatric intensive care unit mortality, longer length of stay and prolonged mechanical ventilation in critically ill children: a two-center retrospective cohort study. Crit Care. 2011; 15(3)[DOI][PubMed]
  • 6. Mehta P, Sinha A, Sami A, Hari P, Kalaivani M, Gulati A, et al. Incidence of acute kidney injury in hospitalized children. Indian Pediatr. 2012; 49(7): 537-42[DOI][PubMed]
  • 7. Winterberg PD, Lu CY. Acute kidney injury: the beginning of the end of the dark ages. Am J Med Sci. 2012; 344(4): 318-25[DOI][PubMed]
  • 8. Al-Ismaili Z, Palijan A, Zappitelli M. Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application. Pediatr Nephrol. 2011; 26(1): 29-40[DOI][PubMed]
  • 9. Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr. 2011; 23(2): 194-200[DOI]
  • 10. Ostermann M, Philips BJ, Forni LG. Clinical review: Biomarkers of acute kidney injury: where are we now? Crit Care. 2012; 16(5): 233[DOI][PubMed]
  • 11. Kashani K, Cheungpasitporn W, Ronco C. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption. Clin Chem Lab Med. 2017; [DOI][PubMed]
  • 12. Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008; 148(11): 810-9[DOI][PubMed]
  • 13. Nickolas TL, Schmidt-Ott KM, Canetta P, Forster C, Singer E, Sise M, et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol. 2012; 59(3): 246-55[DOI][PubMed]
  • 14. Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, et al. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med. 2010; 56(1): 52-59 e1[DOI][PubMed]
  • 15. Soto K, Papoila AL, Coelho S, Bennett M, Ma Q, Rodrigues B, et al. Plasma NGAL for the diagnosis of AKI in patients admitted from the emergency department setting. Clin J Am Soc Nephrol. 2013; 8(12): 2053-63[DOI][PubMed]
  • 16. van den Bergh FA, Kolkman JJ, Russel MG, Vlaskamp RT, Vermes I. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease]. Ned Tijdschr Geneeskd. 2003; 147(48): 2360-5[PubMed]
  • 17. Fujiu K, Manabe I, Nagai R. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest. 2011; 121(9): 3425-41[DOI][PubMed]
  • 18. Schrezenmeier EV, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM. Biomarkers in acute kidney injury - pathophysiological basis and clinical performance. Acta Physiol (Oxf). 2017; 219(3): 554-72[DOI][PubMed]
  • 19. Ebbing J, Mathia S, Seibert FS, Pagonas N, Bauer F, Erber B, et al. Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder. World J Urol. 2014; 32(6): 1485-92[DOI][PubMed]
  • 20. Kim AJ, Ro H, Kim H, Chang JH, Lee HH, Chung W, et al. Klotho and S100A8/A9 as Discriminative Markers between Pre-Renal and Intrinsic Acute Kidney Injury. PLoS One. 2016; 11(1)[DOI][PubMed]
  • 21. Heller F, Frischmann S, Grunbaum M, Zidek W, Westhoff TH. Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury. Clin J Am Soc Nephrol. 2011; 6(10): 2347-55[DOI][PubMed]
  • 22. Seibert FS, Pagonas N, Arndt R, Heller F, Dragun D, Persson P, et al. Calprotectin and neutrophil gelatinase-associated lipocalin in the differentiation of pre-renal and intrinsic acute kidney injury. Acta Physiol (Oxf). 2013; 207(4): 700-8[DOI][PubMed]
  • 23. Ebbing J, Seibert FS, Pagonas N, Bauer F, Miller K, Kempkensteffen C, et al. Dynamics of Urinary Calprotectin after Renal Ischaemia. PLoS One. 2016; 11(1)[DOI][PubMed]
  • 24. Chang CH, Yang CH, Yang HY, Chen TH, Lin CY, Chang SW, et al. Urinary Biomarkers Improve the Diagnosis of Intrinsic Acute Kidney Injury in Coronary Care Units. Medicine (Baltimore). 2015; 94(40)[DOI][PubMed]
  • 25. Tepel M, Borst C, Bistrup C, Marcussen N, Pagonas N, Seibert FS, et al. Urinary calprotectin and posttransplant renal allograft injury. PLoS One. 2014; 9(11)[DOI][PubMed]
  • 26. Szeto CC, Kwan BC, Lai KB, Lai FM, Chow KM, Wang G, et al. Urinary expression of kidney injury markers in renal transplant recipients. Clin J Am Soc Nephrol. 2010; 5(12): 2329-37[DOI][PubMed]
  • 27. Pepper RJ, Wang HH, Rajakaruna GK, Papakrivopoulou E, Vogl T, Pusey CD, et al. S100A8/A9 (calprotectin) is critical for development of glomerulonephritis and promotes inflammatory leukocyte-renal cell interactions. Am J Pathol. 2015; 185(5): 1264-74[DOI][PubMed]
  • 28. Westhoff JH, Fichtner A, Waldherr S, Pagonas N, Seibert FS, Babel N, et al. Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury. Pediatr Nephrol. 2016; 31(12): 2353-63[DOI][PubMed]
  • 29. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11(2)[DOI][PubMed]
  • 30. Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr. 1985; 106(3): 522-6[DOI][PubMed]
  • 31. Bellomo R, Bagshaw S, Langenberg C, Ronco C. Pre-renal azotemia: a flawed paradigm in critically ill septic patients? Contrib Nephrol. 2007; 156: 1-9[DOI][PubMed]
  • 32. Basu RK, Wong HR, Krawczeski CD, Wheeler DS, Manning PB, Chawla LS, et al. Combining functional and tubular damage biomarkers improves diagnostic precision for acute kidney injury after cardiac surgery. J Am Coll Cardiol. 2014; 64(25): 2753-62[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Iranian Journal of Pediatrics accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check